Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.412, 2003-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Imatinib mesylate in the treatment of chronic myeloid leukaemia
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. :
Access to resources
Recommend
Iressa linked to tumour haemorrhage, warns AstraZeneca
Reactions Weekly, Vol. 1, Iss. 1132, 2006-01 ,pp. :
Imatinib mesylate normalised the bone marrow of patients with chronic myeloid leukaemia
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :
An IV formulation of esomeprazole [Nexium] has been launched in the UK by AstraZeneca
Inpharma, Vol. 1, Iss. 1431, 2004-01 ,pp. :
By Sayitoglu M Haznedaroğlu IC Hatirnaz O Erbilgin Y Aksu S Koca E Adiguzel C Bayik M Akalin I Gülbas Z Akay M Unal A Kaynar L Ovali E Yilmaz M Yenerel M Dagdas S Ozet G Ar C Aydin Y Soysal T Durgun B Ozcebe O Tukun A Ilhan O Ozbek U
The Journal of International Medical Research, Vol. 37, Iss. 4, 2009-07 ,pp. :